Advertisement

Topics

Companies Related to "Effect of Rosuvastatin on Coronary Flow Reserve in Hypertensive Patients With Cardiovascular Risk" [Most Relevant Company Matches] RSS

01:06 EST 16th February 2019 | BioPortfolio

Here are the most relevant search results for "Effect of Rosuvastatin on Coronary Flow Reserve in Hypertensive Patients With Cardiovascular Risk" found in our extensive corporate database of over 50,000 company records.

Showing "Effect Rosuvastatin Coronary Flow Reserve Hypertensive Patients With" Companies 1–25 of 4,300+

Relevant

Rcadia Medical Imaging Ltd.

Rcadia Medical Imaging develops and markets automated image processing software products for blood vessel analysis in patients with suspected cardiovascular disease. The company's first FDA-cleared product, the COR Analyzer® System, provides fully automated analysis of Coronary CT angiography to enable the practical application of cCTA in detecting severe coronary artery disease. The COR Analyzer...


Rcadia Medical Imaging

Rcadia Medical Imaging develops and markets automated image processing software products for blood vessel analysis in patients with suspected cardiovascular disease. The company's first FDA-cleared product, the COR Analyzer® System, provides fully automated, real-time analysis of Coronary CT angiography to enable the practical application of cCTA in detecting severe coronary artery disease. The C...

Rcadia Medical Imaging, Ltd.

Rcadia Medical Imaging develops and markets automated image processing software products for blood vessel analysis in patients with suspected cardiovascular disease. The company's first FDA-cleared product, the COR Analyzer® System, provides fully automated, real-time analysis of Coronary CT angiography to enable the practical application of cCTA in detecting severe coronary artery disease. The C...


PlaqueTec Ltd.

PlaqueTec offers a first-of-its-kind catheter technology for cardiologists to routinely assess inflammation in the coronary artery, and better understand residual inflammatory risk. It has been proven to detect inflammatory molecules across the site of coronary artery disease (CAD), and can discriminate between patients with greater and lesser levels of co...

Tayside Flow Technologies Limited

TFT was formed in October 1998 as a spinout company from Tayside University Hospitals NHS TrustTayside Flow Technologies Ltd (TFT) is focused on the research, development and early stage commercialisation of vascular devices based on a new understanding of blood flow dynamics - Spiral Laminar Flow (SLF™ technology). The cardiovascular market is estimated at £11bn ($18bn equivalent) worldwide wi...

Woodford Reserve

Woodford Reserve, the "Official Bourbon of the Kentucky Derby", is crafted at the historic Woodford Reserve Distillery in Versailles, Kentucky - the heart of thoroughbred country. Woodford Reserve is one of the fine spirits produced and marketed by the Brown-Forman Corporation (NYSE: BF-B). For 140 years, Brown-Forman has enriched the experience of life by responsibly building fine quality beverag...

Ischemix

Ischemix is a privately-held drug discovery company with a portfolio of small molecule therapeutic compounds. The first of these compounds is targeted to reduce cell death and organ damage due to initial interruption and subsequent resumption of blood flow associated with cardiac surgeries and interventional procedures such as percutaneous coronary interve...

Cardica

Cardica designs and manufactures proprietary automated anastomotic systems used by surgeons to perform coronary artery bypass graft (CABG) surgery. In CABG procedures, veins or arteries are used to construct alternative conduits to restore blood flow beyond narrowed or occluded portions of coronary arteries, "bypassing" the narrowed or occluded portion of the artery that is impairing blood flow to...

Flow Forward Medical Inc.

Flow Forward is developing a novel approach to rapidly establish high-quality vascular access sites for hemodialysis. The AFE System is a small, temporary, external blood pump designed to stimulate flow-mediated dilation to make more patients eligible for an arteriovenous fistula (AVF) and increase success rates after surgery. Establishment of a reliable A...

Moor Instruments Ltd

Advanced laser Doppler imaging and laser Doppler monitoring products for microvascular blood flow assessment and a range of unique protocol products designed to provide flexible and reproducible stimulation of flow. Investigate the effect of postural changes, vaso-active drug application, thermal effects, systemic pressure changes and more.Laser Doppler and Temperature Monitoring The DRT4 is our m...

Imposter Research

IMPOSTER is the name of a medical research study of patients with muscle symptoms while taking cholesterol lowering therapies called statins. Several important findings from this study have been published and have raised questions about the safety of statin therapy for patients with muscle complaints. This website was developed to address those questions and to share what is known about statin mu...

CathWorks

CathWorks is a medical technology company focused on applying its advanced computational science platform to optimize PCI therapy decisions and elevate coronary angiography from visual assessment to an objective FFR-based decision-making tool for physicians. FFR-guided PCI decision-making is proven to provide significant clinical benefits for patients with...

PLC Systems

PLC is a global leader in the development of products for performing a revolutionary new surgical procedure known as transmyocardial revascularization (TMR). TMR offers a completely new medical treatment option for patients who suffer from severe coronary artery disease. Coronary artery disease is the leading cause of death in the United States. Working with leading researchers and premier heart...

Eminent effect

The eminent effect is a consultancy aiming to stand out from the crowd in tackling many of today’s people and business challenges. The company offers organisation specific training, development, sales/marketing and interim management solutions not off the shelf packages.Primarily working within the NHS, Pharmaceutical and Biotechnology sectors, the eminent effect personnel can offer experience g...

CardioVascular BioTherapeutics

CardioVascular BioTherapeutics, Inc. (OTC/BB: CVBT) is a biopharmaceutical company focused on developing protein drug candidates to be used in the treatment of cardiovascular disease, the worldwide leading cause of death. The Company is developing injectable and topical formulations of its active pharmacological ingredient (API) to facilitate the growth of new blood vessels (angiogenesis) in the h...

Miracor Medical Systems GmbH

Based in Vienna, Austria, privately held Miracor is commercializing a unique and potentially disruptive technology, PICSO®, for acute coronary syndrome (ACS), heart failure, and cardiac surgery patients. The Company’s objective is to establish PICSO® as the standard of care for heart attack patients, thereby improving their quality of life. The ...

SIERRA INSTRUMENTS INC.

Our Mission: To be the leading manufacturer of mass flow meters, mass flow controllers, and partial flow sampling systems in the world in terms of quality, delivery, price, innovation, and customer support.

InVasc Therapeutics, Inc.

InVasc Therapeutics, Inc., headquartered in Tucker, Georgia, is a biopharmaceutical company developing drugs to mitigate risks associated with cardiometabolic diseases. Cardiovascular and metabolic diseases such as diabetes, hypertension, stroke and dyslipidemia are the leading causes of morbidity and mortality worldwide. The Company plans to file an IND l...

Sunshine Heart, Inc.

Sunshine Heart (ASX:SHC) is a global medical device company committed to novel cardiac and coronary therapy. The company is currently developing the C-Pulse® Heart Assist System, an implantable, non-blood contacting, heart assist therapy for the treatment of moderate to severe heart failure which can be implanted using a minimally invasive procedure. C-...

Roswell Park Cancer Institute Laboratory of Flow Cytometry

The Laboratory of Flow Cytometry was formed in 1988 to provide a cutting edge core facility in flow cytometry. The goals of the laboratory are to provide multiparameter flow cytometry services for clinical diagnosis and follow-up and to basic and clinical research investigators, provide an educational outreach program in flow cytometry, and develop new applications and instrumentation. To accompli...

Flow Sciences, Inc.

Flow Sciences, Inc. (FSI) designs and manufactures safety containment solutions for Research and Development Laboratories, Pilot Facilities, Automation Equipment and Robotics, Manufacturing and Production Plants. Flow Sciences brings improved and customized products to the demanding marketplace ensuring safety and quality solutions. Flow Sciences’ containment products and systems provide many be...

NOVOSTE

Novoste Corporation, based in Atlanta, Georgia, develops advanced medical treatments for coronary and vascular diseases and is the worldwide leader in vascular brachytherapy - radiation therapy delivered inside a blood vessel to prevent its reclosure (restenosis) following balloon angioplasty and other catheter-based interventional procedures. The NovosteT Beta-CathT System is commercially availab...

Arteriocyte, Inc.

Arteriocyte’s focus is the development of stem cell-based therapies to treat ischemia in patients suffering from coronary artery disease, peripheral vascular disease, stroke, and renal ischemia. The Company was founded in January of 2004 and is based upon more than 4 years of NIH sponsored research utilizing stem cells to stimulate angiogenesis (new vessel growth). Arteriocyte’s development pr...

InfraReDx, Inc.

InfraReDx, Inc., headquartered in Burlington, Massachusetts, is a privately-funded medical device company founded in 1998 and focused on intravascular characterization of disease in the coronary arteries. InfraReDx is the maker of the LipiScan(TM) system, a novel near-infrared (NIR) spectroscopy catheter that can detect the lipid core coronary plaques suspected to cause most heart attacks and know...

Case Western Reserve University


More From BioPortfolio on "Effect of Rosuvastatin on Coronary Flow Reserve in Hypertensive Patients With Cardiovascular Risk"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks